Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation

被引:15
作者
Antonelli, Guido [1 ]
Focosi, Daniele [2 ]
Turriziani, Ombretta [1 ]
Tuccori, Marco [3 ,4 ]
Brandi, Rossella [5 ]
Fillo, Silvia [5 ]
Ajassa, Camilla [6 ]
Lista, Florigio [5 ]
Mastroianni, Claudio M. [6 ]
机构
[1] Sapienza Univ Rome, Sapienza Univ Hosp Policlin Umberto I, Dept Mol Med, Rome, Italy
[2] Pisa Univ Hosp, North Western Tuscany Blood Bank, Via Paradisa 2, I-56124 Pisa, Toscana, Italy
[3] Univ Pisa, Dept Clin & Expt Med, Unit Pharmacol & Pharmacovigilance, Pisa, Italy
[4] Pisa Univ Hosp, Unit Adverse Drug React Monitoring, Pisa, Italy
[5] Army Med Ctr, Dept Sci, Rome, Italy
[6] Sapienza Univ Hosp Policlin Umberto I, Dept Publ Hlth & Infect Dis, Rome, Italy
关键词
D O I
10.1016/j.cmi.2022.06.029
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:1657 / 1658
页数:2
相关论文
共 6 条
[1]   Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19) [J].
Boucau, Julie ;
Uddin, Rockib ;
Marino, Caitlin ;
Regan, James ;
Flynn, James P. ;
Choudhary, Manish C. ;
Chen, Geoffrey ;
Stuckwisch, Ashley M. ;
Mathews, Josh ;
Liew, May Y. ;
Singh, Arshdeep ;
Reynolds, Zahra ;
Iyer, Surabhi L. ;
Chamberlin, Grace C. ;
Vyas, Tammy D. ;
Vyas, Jatin M. ;
Turbett, Sarah E. ;
Li, Jonathan Z. ;
Lemieux, Jacob E. ;
Barczak, Amy K. ;
Siedner, Mark J. .
CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) :E526-E529
[2]  
Center for Drug Evaluation and Research (CDER), REV EN US AUTH EUA P
[3]  
Girardin F, 2022, CLIN MICROBIOL INFEC
[4]  
Gupta K., 2022, Res. Square, DOI [10.21203/rs.3.rs-1588371/v1, DOI 10.21203/RS.3.RS-1588371/V1]
[5]   Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 [J].
Hammond, Jennifer ;
Leister-Tebbe, Heidi ;
Gardner, Annie ;
Abreu, Paula ;
Bao, Weihang ;
Wisemandle, Wayne ;
Baniecki, MaryLynn ;
Hendrick, Victoria M. ;
Damle, Bharat ;
Simon-Campos, Abraham ;
Pypstra, Rienk ;
Rusnak, James M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (15) :1397-1408
[6]   Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2 [J].
Takashita, Emi ;
Kinoshita, Noriko ;
Yamayoshi, Seiya ;
Sakai-Tagawa, Yuko ;
Fujisaki, Seiichiro ;
Ito, Mutsumi ;
Iwatsuki-Horimoto, Kiyoko ;
Halfmann, Peter ;
Watanabe, Shinji ;
Maeda, Kenji ;
Imai, Masaki ;
Mitsuya, Hiroaki ;
Ohmagari, Norio ;
Takeda, Makoto ;
Hasegawa, Hideki ;
Kawaoka, Yoshihiro .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (15) :1475-1477